The comprehensive study on the therapeutic effects of baicalein for the treatment of COVID-19 in vivo and in vitro

Junke Song(Pingdingshan University), Guanhua Du(Shanghai Jiao Tong University), Shiying Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Qi Lv(Chinese Academy of Medical Sciences & Peking Union Medical College), Hongqi Liu(Chinese PLA General Hospital), Yang Lü(Chinese Academy of Medical Sciences & Peking Union Medical College), Shengqian Yang(Chinese Academy of Medical Sciences & Peking Union Medical College), Dezhi Yang(Gansu Coalfield Geology Bureau), Jinhua Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhang Li(Chongqing Academy of Chinese Materia Medica), Wen Zhang(Xidian University), Ailin Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Shuo Tian(Chinese PLA General Hospital), Yanfeng Xu(Chinese Academy of Medical Sciences & Peking Union Medical College), Fengdi Li(Institute of Laboratory Animal Science), Biyu Hou(Kunming Institute of Zoology), Tianyi Yuan(Xinjiang Medical University), Xiaozhong Peng(Chinese Academy of Medical Sciences & Peking Union Medical College)
Biochemical Pharmacology
October 26, 2020
10.1016/j.bcp.2020.114302
Cited by 160

Related Papers

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
|eLife|2012|2.1k
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells
|Cell|2020|1.4k
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
|Nature|2020|1.2k
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
|Nature|2020|849